Hegazy Mona, Saleh Shereen A, Ezzat Ahmed, Behiry Mervat E
Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Internal Medicine, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
Diabetes Metab Syndr Obes. 2020 Feb 10;13:297-305. doi: 10.2147/DMSO.S229590. eCollection 2020.
Limited data are available regarding the role of triglycerides, cholesterol and lipoproteins ratios as risk factors for nonalcoholic fatty liver disease (NAFLD) progression. In the present study, the investigators aimed to investigate the value of cardiovascular risk ratios of triglycerides, cholesterol, and lipoproteins as predictors of nonalcoholic steatohepatitis (NASH) and the correlation of such ratios with disease severity.
This study included 131 overweight and obese patients with NAFLD who were divided into NASH, borderline NASH, and non-NASH fatty liver (NNFL) subgroups according to NAFLD activity score (NAS) in liver biopsy, and 60 healthy participants as a control group. Lipid profile and lipid ratios including triglycerides/HDL (TGs/HDL), low-density lipoprotein/high-density lipoprotein (LDL/HDL) and total cholesterol/HDL (TC/HDL) ratios were measured.
Significantly higher triglycerides/HDL ratio was found in NASH and borderline NASH, while higher cholesterol/HDL ratio was found in borderline NASH in comparison to controls. There were positive correlations between TGs/HDL and steatosis, ballooning, inflammation, BMI, and NAS; between LDL/HDL and inflammation; and between cholesterol/HDL and BMI, steatosis, and NAS. The highest AUC was that of TG/HDL (0.744), at a cut-off point of 3, with 71.8% sensitivity and 76.8% specificity.
Triglycerides, cholesterol and lipoprotein ratios showed higher levels in NASH and correlated with NAFLD severity, and above these cut-off ratios, we can rule in the NASH cases which confer also the cardiovascular morbidities. Structured lipid ratios could serve as markers to screen NASH progression from simple steatosis cases and clarify the link of NASH with the cardiovascular risk prediction in overweight and obese patients.
关于甘油三酯、胆固醇及脂蛋白比值作为非酒精性脂肪性肝病(NAFLD)进展风险因素的作用,现有数据有限。在本研究中,研究者旨在探讨甘油三酯、胆固醇及脂蛋白的心血管风险比值作为非酒精性脂肪性肝炎(NASH)预测指标的价值,以及这些比值与疾病严重程度的相关性。
本研究纳入了131例超重和肥胖的NAFLD患者,根据肝活检中的NAFLD活动评分(NAS)将其分为NASH、临界NASH和非NASH脂肪性肝病(NNFL)亚组,并纳入60名健康参与者作为对照组。测量血脂谱及血脂比值,包括甘油三酯/高密度脂蛋白(TGs/HDL)、低密度脂蛋白/高密度脂蛋白(LDL/HDL)和总胆固醇/高密度脂蛋白(TC/HDL)比值。
与对照组相比,NASH和临界NASH患者的甘油三酯/HDL比值显著更高,而临界NASH患者的胆固醇/HDL比值更高。TGs/HDL与脂肪变性、气球样变、炎症、BMI和NAS之间存在正相关;LDL/HDL与炎症之间存在正相关;胆固醇/HDL与BMI、脂肪变性和NAS之间存在正相关。最高的曲线下面积(AUC)是TG/HDL的(0.744),截断点为3时,灵敏度为71.8%,特异性为76.8%。
NASH患者的甘油三酯、胆固醇及脂蛋白比值较高,且与NAFLD严重程度相关,高于这些截断比值时,我们可以判定为NASH病例,这些病例也伴有心血管疾病。结构化的血脂比值可作为从单纯脂肪变性病例中筛查NASH进展的标志物,并阐明NASH与超重和肥胖患者心血管风险预测之间的联系。